HIV-1 remodels the spatial organization of its co-receptor, CXCR4, on T cell membranes, showing that viral entry requires receptor clustering rather than simple receptor binding.
Researchers identify GPNMB as a driver of Parkinson’s disease spread and demonstrate that monoclonal antibodies can block its activity to slow neurodegeneration.